Samsung Biologics company profile

207940 · KRX · KRW

Compare Samsung Biologics
₩1,381,000.00Change from previous close: −2.33%Absolute change: −₩33,000.00

Close · November 18, 2026

Company profile

Samsung Biologics has 5,326 employees and is headquartered in Incheon, South Korea.

The business centres on manufacturing biopharmaceutical products, which it also commercializes, distributes and sells. Its development work runs from cell line development and process development to analytical development and non-GMP and CGMP manufacturing. Downstream, it operates aseptic filling, freeze-drying, packaging and cold-chain logistics, alongside quality services such as stability studies, environmental monitoring and biosafety testing. Its portfolio also includes antibody-drug conjugates and mRNA products, and its customers and sales reach South Korea, Europe, the United States and other international markets.

In the fiscal year ended December 2025, revenue totalled 4,557.0 billion won, up 30.3% from the prior year, while net income reached 1,784.4 billion won. The company employed 5,326 people and has its headquarters in Incheon, South Korea, where it was set up in 2011.

Company facts

Industry
Biotechnology
Headquarters
300, Songdo bio-daero, Incheon
Employees
5,326
Chief executive
John Chongbo Rim
Founded
2011
Fiscal year
January - December
Listing
207940 · KRX
Currency
KRW
ISIN
KR7207940008

Samsung Biologics and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Samsung Biologics207940South Korea$49.26B5,32645.5%31.2
CSLCSLAustralia$64.31B29,00026.8%—
Celltrion068270South Korea$36.53B2,95631.6%31.4
WuXi Biologics (Cayman)2269Hong Kong SAR China$24.29B14,70532.4%35.1
Innovent Biologics1801Hong Kong SAR China$18.84B8,7547.4%111.5
Sichuan Kelun-Biotech Biopharmaceutical6990Hong Kong SAR China$13.65B2,300-0.2%—

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Samsung Biologics with its competitors